Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential

Page 5 of 5

6. Apogee Therapeutics, Inc. (NASDAQ:APGE)

Perceptive Advisors’ Stake: $176 Million

Analyst Upside Potential: 68%

Elite money managers are aggressively accumulating Apogee Therapeutics, Inc. (NASDAQ:APGE) stock, viewing it as the primary challenger to established blockbuster drugs in the immunology space. The firm recently released positive Phase 2 data for its lead candidate, Zumilokibart. The trial demonstrated that roughly 75% to 85% of patients maintained their response with dosing just every 3 or 6 months. Investors are betting that Apogee’s extended half-life technology will disrupt the market currently dominated by Sanofi’s Dupixent. Analysts note that a once-every-six-months injection offers a massive lifestyle advantage over Dupixent’s every-two-week requirement. Following the positive clinical data, Apogee successfully executed a heavily oversubscribed public offering.

In March, Apogee Therapeutics, Inc. (NASDAQ:APGE) closed a public offering raising $403 million in gross proceeds. Hedge funds view this massive capital raise as a de-risking event. The company now has a cash runway that extends into 2028, allowing it to fund its Phase 3 atopic dermatitis trials, set to begin in late 2026, and its asthma program without further dilution. The inflammatory and immunology market is one of the largest in healthcare. Analysts from Stifel and Guggenheim have recently set price targets as high as $110–$130, citing Apogee’s potential to capture market share from $14 billion-$20 billion drugs like Dupixent and Humira.

While we acknowledge the potential of APGE to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than APGE and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see Billionaire Joe Edelman’s 5 Stock Picks with Huge Upside Potential.

READ NEXT: Israel Englander Stock Portfolio: Top 10 Stock Picks and Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential.

Disclosure: None. Follow Insider Monkey on Google News.

Page 5 of 5